Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy MeiraGTx (MGTX) stock

Learn how to easily invest in MeiraGTx stock.

MeiraGTx Holdings plc is a biotechnology business based in the US. MeiraGTx shares (MGTX) are listed on the NASDAQ and all prices are listed in US Dollars. MeiraGTx employs 233 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in MeiraGTx

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MGTX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

MeiraGTx stock price (NASDAQ: MGTX)

Use our graph to track the performance of MGTX stocks over time.

MeiraGTx shares at a glance

Information last updated 2021-07-24.
Latest market close$13.79
52-week range$11.81 - $18.45
50-day moving average $15.23
200-day moving average $14.95
Wall St. target price$35.57
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.62

Buy MeiraGTx shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy MeiraGTx stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

MeiraGTx price performance over time

Historical closes compared with the close of $13.79 from 2021-05-28

1 week (2021-07-16) N/A
1 month (2021-06-25) -14.72%
3 months (2021-04-27) -4.77%
6 months (2021-01-23) N/A
1 year (2020-07-23) N/A
2 years (2019-07-23) N/A
3 years (2018-07-23) N/A
5 years (2016-07-23) N/A

MeiraGTx financials

Revenue TTM $15.9 million
Gross profit TTM $15.6 million
Return on assets TTM -13.37%
Return on equity TTM -32.5%
Profit margin 0%
Book value $4.99
Market capitalisation $648.7 million

TTM: trailing 12 months

Shorting MeiraGTx shares

There are currently 601,854 MeiraGTx shares held short by investors – that's known as MeiraGTx's "short interest". This figure is 37.1% up from 439,064 last month.

There are a few different ways that this level of interest in shorting MeiraGTx shares can be evaluated.

MeiraGTx's "short interest ratio" (SIR)

MeiraGTx's "short interest ratio" (SIR) is the quantity of MeiraGTx shares currently shorted divided by the average quantity of MeiraGTx shares traded daily (recently around 172451.00286533). MeiraGTx's SIR currently stands at 3.49. In other words for every 100,000 MeiraGTx shares traded daily on the market, roughly 3490 shares are currently held short.

However MeiraGTx's short interest can also be evaluated against the total number of MeiraGTx shares, or, against the total number of tradable MeiraGTx shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MeiraGTx's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 MeiraGTx shares in existence, roughly 10 shares are currently held short) or 0.0244% of the tradable shares (for every 100,000 tradable MeiraGTx shares, roughly 24 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against MeiraGTx.

Find out more about how you can short MeiraGTx stock.

MeiraGTx share dividends

We're not expecting MeiraGTx to pay a dividend over the next 12 months.

MeiraGTx share price volatility

Over the last 12 months, MeiraGTx's shares have ranged in value from as little as $11.81 up to $18.45. A popular way to gauge a stock's volatility is its "beta".

MGTX.US volatility(beta: 1.31)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MeiraGTx's is 1.3097. This would suggest that MeiraGTx's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

MeiraGTx overview

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. The company was incorporated in 2015 and is based in New York, New York.

MeiraGTx in the news

There are no recent company news

Frequently asked questions

What percentage of MeiraGTx is owned by insiders or institutions?
Currently 12.668% of MeiraGTx shares are held by insiders and 62.804% by institutions.
How many people work for MeiraGTx?
Latest data suggests 233 work at MeiraGTx.
When does the fiscal year end for MeiraGTx?
MeiraGTx's fiscal year ends in December.
Where is MeiraGTx based?
MeiraGTx's address is: 430 East 29th Street, New York, NY, United States, 10016
What is MeiraGTx's ISIN number?
MeiraGTx's international securities identification number is: KYG596651029
What is MeiraGTx's CUSIP number?
MeiraGTx's Committee on Uniform Securities Identification Procedures number is: G59665102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site